TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/20 16:48 | 8/5/20 | MNTA | Momenta Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | D | S.d | -330 | 33.00 | 0 | -10 | -42 | 14 | D | |||||||||||||||
7/30/20 19:03 | 7/29/20 | MNTA | Momenta Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | D | S.d | -300 | 30.00 | 0 | -10 | -42 | 14 | D | |||||||||||||||
2/14/14 20:32 | 2/13/14 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | NJ | D | S.d | -233 | 37.70 | 0 | -6 | -41 | 9 | D | |||||||||||||||
11/2/07 09:06 | 10/30/07 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | O | EVP | S.d | -2,850 | 76.00 | 0 | -38 | -73 | 14 | D | ||||||||||||||
7/19/05 09:59 | 7/15/05 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | O | EVP | S.d | -508 | 68.61 | 0 | -7 | -57 | 6 | D | ||||||||||||||
5/16/05 12:27 | 5/12/05 | GENZ | Genzyme Corp | MA | Health | BioPrd | Biological Products, (No Diag | Gemayel Georges | MA | O | EVP | S.d | -1,613 | 64.50 | 0 | -25 | -89 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |